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Abstract
Microbiota niches have space and/or nutrient restrictions, which has led to the
coevolution of cooperation, specialisation, and competition within the population.
Different animal and environmental niches contain defined resident microbiota that
tend to be stable over time and offer protection against undesired intruders. Yet
fluxes can occur, which alter the composition of a bacterial population. In humans,
the microbiota are now considered a key contributor to maintenance of health and
homeostasis, and its alteration leads to dysbiosis. The bacterial type VI secretion sys-
tem (T6SS) transports proteins into the environment, directly into host cells or can
function as an antibacterial weapon by killing surrounding competitors. Upon contact
with neighbouring cells, the T6SS fires, delivering a payload of effector proteins. In
the absence of an immunity protein, this results in growth inhibition or death of prey
leading to a competitive advantage for the attacker. It is becoming apparent that the
T6SS has a role in modulating and shaping the microbiota at multiple levels, which is
the focus of this review. Discussed here is the T6SS, its role in competition, key
examples of its effect upon the microbiota, and future avenues of research.
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1 | INTRODUCTION
The microbiota are a community of microorganisms composed of bac-
teria, archaea, protists, fungi, and viruses. Within these mixed commu-
nities, organisms compete for limited resources and space. These
drivers have forced the coevolution of mechanisms of specialisation
collaboration and competition. Bacteria are no exception; these social
organisms contend for survival and resources for reproduction in the
microbiota arena. They have multiple strategies to fight competitors
and predators as well as for subverting host cells. In their armament
are molecules (e.g., antibiotics, colicins, and siderophores) as well as
specialised secretion systems for the export of functional proteins
termed effectors. The type VI secretion system (T6SS) delivers effec-
tors into cells using a puncturing mechanism akin to that of bacterio-
phages (Figure 1; Nguyen et al., 2018). This system is present in more
than 25% of all Gram-negative bacteria including pathogens and envi-
ronmental symbiotic or commensal microorganisms (Bingle, Bailey, &
Pallen, 2008). The T6SS forms three discrete multiprotein subunit
structures (Figure 1; Nguyen et al., 2018). The membrane complex
TssJLM defines the site of T6SS assembly and enables the baseplate
to couple, which facilitates formation of a tail-like structure. A con-
tractile sheath is composed of repeating subunits of TssB/C (VipA/B)
stored in a high-energy state and wraps the inner tube, composed of
Hcp rings. Firing of the T6SS leads to a coordinated collapse of the
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sheath, which propels the Hcp tube through the membrane complex.
At the tip of the Hcp tube is the puncturing device made of a trimer
of VgrG proteins and PAAR protein cap, which facilitates puncture of
both producing and target cell membranes. Loaded on the secretion
machine are two classes of effectors (Figure 1). The “evolved” or “spe-
cialised” class has effector domains fused to structural T6SS compo-
nents, that is, Hcp, VgrG, or PAAR proteins (Coulthurst, 2019;
Hachani, Wood, & Filloux, 2016). The “cargo” effectors interact with
these aforementioned proteins either directly or through specific
adaptors proteins (Coulthurst, 2019). These effectors are delivered
extracellularly, into eukaryotic target cells such as amoeba, animal
cells, or fungal competitors, or more commonly into bacterial competi-
tors to kill or suppress growth (Figures 1 and 2; Coulthurst, 2019;
Hachani et al., 2016; Lin et al., 2017; Trunk et al., 2018).
2 | T6SS AND ANTIMICROBIAL ACTIVITY
T6SS antibacterial effectors target vital bacterial cellular functions and
result in growth stasis or death of competing bacteria (Figure 2).
These effectors are encoded in effector–immunity pairs (also called
toxin/immunity or effector modules) with the immunity/antidote
preventing intoxication from T6SS active siblings (Coulthurst, 2019).
The effectors secreted by the T6SSs are classified according to their
targets and functions (Russell, Peterson, & Mougous, 2014). Amongst
antibacterial effectors targets are nucleic acids cleaved by nucleases
(Ma, Hachani, Lin, Filloux, & Lai, 2014; Pissaridou et al., 2018), cell wall
degraded by peptidoglycan amidases or hydrolases (Russell et al.,
2012), membranes permeabilised by lipases/phospholipases (Russell
et al., 2013; Whitney et al., 2013), or pore-forming toxins (LaCourse
F IGURE 1 Schematic of the T6SS from host to effector delivery: (I) effectors coupling for T6SS delivery. “Cargo” effectors noncovalently
interact with structural components (VgrG/PAAR/Hcp), whereas “specialised” or “evolved” effectors contain additional effector domains within
one protein (VgrG/PAAR/Hcp). (II) Protein subcomplexes of the T6SS. (III) Model of contraction-based firing. The T6SS assembles in an extended
conformation, fires, and is then disassembled for recycling. Delivery of effectors (purple) into competing cells results in growth stasis or death.
(IV) Antibacterial activity of the T6SS in the intestine. Top panel shows T6SS-mediated defence by the microbiota (blue) against pathogen (red).
Bottom panel shows invasion and killing of microbiota by pathogen. Dotted outlines and pale colour indicate dead cells. (V) Model of human with
outline of the intestine focusing on region of interest
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et al., 2018; Miyata, Unterweger, Rudko, & Pukatzki, 2013). Other
targeted processes are bacterial cell division (e.g., blocking FtsZ poly-
merisation; Ting et al., 2018; Wood et al., 2019), protein synthesis
(Nolan et al., 2019), or availability of dinucleotides such as NADP+
and ATP to cripple prey cells (Ahmad et al., 2019; Whitney et al.,
2015). Some T6SS effectors function as metal ion scavenging
proteins, which may result in starvation instead of cell damage and
impact the community more broadly (Figure 2; Lin et al., 2017).
The delivered effector repertoire determines the T6SS efficacy.
The Pseudomonas aeruginosa H1-T6SS has nine experimentally tested
effectors that target nucleic acids, peptidoglycan, the inner mem-
brane, protein synthesis, NADP+, and the ATP pools (Ahmad et al.,
F IGURE 2 Key functional impact and roles of the T6SS. See text for additional details
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2019; Hachani, Allsopp, Oduko, & Filloux, 2014; Hood et al., 2010;
LaCourse et al., 2018; Nolan et al., 2019; Pissaridou et al., 2018; Rus-
sell et al., 2011; Whitney et al., 2014; Whitney et al., 2015). The
requirement for many distinct T6SS effectors is debatable. An arsenal
of effectors with synergistic biochemical activities may be more
potent than higher levels of one specific effector. Producer cells also
increase the odds of killing different competitors and overcoming
resistance by increasing effectors diversity and their targets. Addition-
ally, certain effectors may have conditional efficacy and be more
impactful under certain environmental conditions (e.g., low pH;
LaCourse et al., 2018). Finally, trans-kingdom effectors target both
eukaryotic and prokaryotic cells, enabling greater functionality for
lower production cost (Jiang, Waterfield, Yang, Yang, & Jin, 2014).
Bioinformatic approaches focusing on conserved motifs, proximity to
known T6SS components, or global genomic and proteomic
approaches continue to uncover additional effectors, indicating that
we are underestimating their number and thus their functions/cellular
targets (Coulthurst, 2019; Jana, Fridman, Bosis, & Salomon, 2019;
Nolan et al., 2019). T6SS-harbouring microorganisms also have multi-
ple independent T6SS clusters; for example, P. aeruginosa encodes
three and Burkholderia up to six (Schell et al., 2007). Overall, this sug-
gests that we are likely scratching the surface of what these systems
are capable of.
With this broad range of functions, it stands to reason that the
T6SS will be employed by bacteria to help gain control of their envi-
ronment/host or to facilitate community balance by eliminating
cheaters and foes (Figure 2).
3 | THE T6SS MODULATES THE
EVOLUTION OF POLYMICROBIAL
COMMUNITIES
A community of bacteria or even multiple strains of one bacterium can
be shaped by the T6SS on the basis of the effector modules present. As
opposed to the core T6SS structural components, which are typically
highly conserved, sequence divergence is frequently observed for effec-
tor modules even within species (Chatzidaki-Livanis, Geva-Zatorsky, &
Comstock, 2016; Pissaridou et al., 2018; Unterweger et al., 2014).
Antibacterial effector–immunity proteins enable social interactions
through recognition of self when the same sets of effector–immunity
proteins are expressed in different strains but can drive antagonism if
different (Figure 2). Opposing strain swarms of Proteus mirabilis form
T6SS-dependent “battle lines” of segregation called Dienes lines (Alteri
et al., 2017). In Vibrio cholerae, related families of effectors (>30%
identity) are associated with immunity proteins whose variation is
far greater (Kirchberger, Unterweger, Provenzano, Pukatzki, & Boucher,
2017; Unterweger et al., 2014). Combinations of distinct effector mod-
ules within a strain further contribute to interstrain incompatibility and
confer a significant competitive advantage over rivals (Unterweger
et al., 2014). T6SS armament can be increased by acquisition of individ-
ual effector modules, or small operons encoding vgrG/hcp/paar and cog-
nate effector modules or in the case of Bacteroidetes via horizontally
acquired entire T6SS operons on integrative conjugative elements with
near 100% identity amongst Bacteroides species (Allsopp et al., 2017;
Coyne, Zitomersky, McGuire, Earl, & Comstock, 2014; Unterweger
et al., 2014). Maintaining ancestral immunity genes or acquiring immu-
nity but not effector genes is a good strategy to cope with T6SS-active
strains in a population at lower cost, such as the C-type immunity gene
in the aux-1 cluster of V. cholerae or the recently described acquired
interbacterial defence gene clusters, which encode arrays of immunity
genes (Alteri et al., 2017; Kirchberger et al., 2017; Ross et al., 2019;
Wexler et al., 2016).
The advantage of the T6SS in polymicrobial populations extends
beyond the simple killing of competitors, preventing their use of nutri-
ents (Figure 2). T6SS-mediated killing that results in lysis of prey cells
leads to the release of nutrients and cellular content. Studies in
V. cholerae (Borgeaud, Metzger, Scrignari, & Blokesch, 2015) and
Acinetobacter baylyi (Ringel, Hu, & Basler, 2017) show that regulation
of the T6SS and DNA uptake is linked. This enables coordinated killing
of prey and DNA acquisition from lysed bacteria, which fosters hori-
zontal gene transfer. Incorporation of this genetic material enables the
acquisition of new antimicrobial resistance genes, pathogenicity
islands, or T6SS effectors/immunity pairs, all of which could provide
an evolutionary advantage (Blokesch, 2017; Borgeaud et al., 2015;
Kirchberger et al., 2017; Thomas, Watve, Ratcliff, & Hammer, 2017).
Acquisition of new effectors may allow successful lineages of bac-
teria to dominate particular environments. One example of this is
within the bee, where the microbiota are dominated by nine bacterial
species (including Gilliamella apicola and Snodgrassella alvi, which are
T6SS+); however, multiple strains coexist within individual bees, hives,
host species, and geographic locations. These two species contain a
massive diversity of putative effectors with 1,112 identified bio-
informatically within 77 strains (Steele, Kwong, Whiteley, & Moran,
2017). A subset of these effector genes was found to be upregulated
in two S. alvi strains when grown within the bee gut, suggesting a role
of the T6SS in either intrastrain competition (between S. alvi) or inter-
species competition with other microbiota (Steele et al., 2017). This
maintenance of the T6SS and diverse effectors suggests that T6SS
provides an advantage and that coevolution amongst bacterial species
is occurring in the bee gut. A second example is in the Hawaiian bob-
tail squid where intraspecies competition by Vibrio fischeri isolates
facilitates colonisation of the light-organ crypts. Here, T6SS+ strains
outcompete T6SS− strains within a single crypt. Contrastingly, two
T6SS+ strains formed spatially segregated but interspersed micro-
colonies with a crypt. Incompatible effector modules and bacterial kill-
ing will prevent mixing similar to the Dienes lines observed in vitro for
P. mirabilis and will highlight that T6SS fighting is occurring and shap-
ing the population within a host (Speare et al., 2018). The T6SS can
also function as a policing mechanism to enforce cooperation. In Bur-
kholderia thailandensis, T6SS-1 and a range of public goods that bene-
fit the overall population are controlled through quorum sensing (QS).
However, QS mutants have a growth advantage over wild type, as
they do not produce public goods (e.g., extracellular proteases) but
gain the benefits of them acting as cheaters in the population. This
growth advantage can be observed in liquid coculture where the
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cheater population rises from 1% of the population to 50% over
3 days. However, the same population grown on solid surfaces stayed
at 1% through the action of the T6SS (Majerczyk, Schneider, & Gre-
enberg, 2016). By linking expression of public goods with antibacterial
T6SS effectors, B. thailandensis has evolved as a hardwired regulatory
system to control cheaters under defined environmental conditions.
4 | T6SS IN PLANT-ASSOCIATED
BACTERIA
It is increasingly becoming apparent that the T6SS provides an advan-
tage in several model systems particularly in an agricultural context.
The majority of T6SSs in plant-associated bacteria described are
involved in competition (Bayer-Santos et al., 2018; Bernal, Allsopp,
Filloux, & Llamas, 2017; Decoin et al., 2014; Haapalainen et al., 2012;
Ma et al., 2014) and only a few in host manipulation (Shyntum et al.,
2015; L. Zhang et al., 2014; Figure 2). A recent study demonstrated
that the T6SSs from the environmental bacterium Pseudomonas putida
act as a mechanism of biocontrol eliciting antibacterial activity against
a panel of resilient phytopathogens including Xanthomonas campestris
and reduce plant symptoms during coinfection in Nicotiana ben-
thamiana plants (Bernal et al., 2017). In agreement with these results,
it was also shown that Pseudomonas fluorescens can protect potato
tubers from the attack of Pectobacterium atrosepticum in a T6SS-
dependent manner (Decoin et al., 2014). Deletion of the T6SS from
Kosakonia endophytes has also been demonstrated to significantly
decrease plant root rhizosphere and endosphere colonisation
(Mosquito et al., 2019).The environmental setting may also modulate
the effectiveness of the T6SS. For example, in vitro, Agrobacterium
tumefaciens is outcompeted by the T6SS of P. aeruginosa. However, in
a plant coinfection assay, the T6SS of A tumefaciens prevails over
P. aeruginosa to gain a competitive advantage (Ma et al., 2014). Plants
species also modulate their environment to promote beneficial
microbes in the root microbiome to protect against soil pathogens
(Lebeis et al., 2015), and future experiments will define the contribu-
tion of the T6SS in this niche.
5 | T6SS IN RESIDENT GUT MICROBIOTA
Given the role of the T6SS, it is reasonable to consider that this sys-
tem could be capable of deeply transforming the gut microbiota,
which may have a great impact on human health. The mammalian gas-
trointestinal tract harbours the densest microbial community currently
known with dysbiosis associated with obesity, inflammatory bowel
disease, and cancer. This community is numerically dominated by
Gram-positive Firmicutes and Gram-negative Bacteroidales and is an
attractive niche to prospect for T6SS interactions. One of the first
studies to discover T6SS clusters in human gut microbiota strains was
by Coyne et al. (2014). They identified the majority of the T6SS struc-
tural genes and a putative effector encoding a recombination hot spot
(Rhs) protein with a deaminase domain and two putative immunities.
Other studies have corroborated this with the identification of puta-
tive T6SS effector modules (e.g., zinc metalloproteases or peptidogly-
can endopeptidase motifs) encoded in the vicinity of vgrG and hcp
genes (Russell, Peterson, et al., 2014; Russell, Wexler, et al., 2014;
D. Zhang, de Souza, Anantharaman, Iyer, & Aravind, 2012). Genomic
analysis identified nine out of the 13 core Proteobacterial T6SS com-
ponents (TssB/C/E/F/G/K, ClpV, VgrG and Hcp) encoded within Bac-
teroidetes gene clusters (Russell, Wexler, et al., 2014). Noticeably
missing were the genes encoding the membrane complex proteins,
but four additional genes, tssN, tssO, tssP, and tssQ, each containing at
least one predicted transmembrane region, may substitute this func-
tion (Coyne, Roelofs, & Comstock, 2016). Sequence divergence of
TssC resulted in the Bacteroides cluster to be designated the T6SSiii,
separate from the Proteobacterial T6SSi (e.g., Pseudomonas or Vibrio
systems) and T6SSii (Francisella) clades (Russell, Wexler, et al., 2014).
An analysis of the core T6SSiii clusters of 205 human gut
Bacteroidales revealed three distinct genetic architectures (GA1, GA2,
and GA3) distinguished by conserved orientation and organisation
within T6SS clusters (Coyne et al., 2016). The role of GA1 and GA2 is
unknown, but putative effector–immunity pairs (e.g., several evolved
PAAR proteins with putative nuclease domains) hint at it being
involved in interbacterial competition (Coyne et al., 2016). Supporting
this notion, multiple species encode the same effector genes within a
single microbiome (Verster et al., 2017). GA1 and GA2 are shared
amongst Bacteroides (Coyne et al., 2016; Coyne et al., 2014), whereas
GA3 is exclusively found in some Bacteroides fragilis strains (Coyne
et al., 2014). Metagenomic and strain analyses have shown a mono-
phyletic group of B. fragilis within individuals, suggesting single coloni-
sation or out-competition events dependent on the effector–
immunity pair genotypes (Verster et al., 2017). An analysis of infant
microbiomes containing B. fragilis is significantly more likely to har-
bour GA3 structural genes (92%) compared with those of adults
(74%), suggesting that GA3 mediates strain level competition early on
in gut microbiota development (Verster et al., 2017). The presence of
GA3 in B. fragilis is also associated with higher relative abundance of
B. fragilis and negatively correlated with Gram-positive Firmicutes
genera (Faecalibacterium, Oscillospira, and Ruminococcus). As Gram-
positive bacteria have not been shown to be targets of the T6SS, the
decreased abundance of these genera in GA3-containing microbiomes
is most likely due to a fitness advantage conferred to GA3+ B. fragilis
and not direct action against Firmicutes (Verster et al., 2017). Several
studies have also demonstrated a role of the GA3 T6SSiii in the gut
microbiota of mice. In competitive colonisation experiments of germ
free mice, a human strain of B. fragilis was able to outcompete in a
T6SSiii-dependent manner, the gut commensal Bacteroides the-
taiotaomicron, which lacks the T6SS (Figure 1; Russell, Wexler, et al.,
2014). Chatzidaki-Livanis et al. (2016) confirmed the expression of the
system and a role in intrastrain killing as the parent outcompeted an
effector–immunity pair mutant. Furthermore, a strain of B. fragilis can
restrict colonisation of the murine host by two pathogenic strains of
enterotoxigenic Bacteroides fragilis and reduced pathogen damage,
which is associated with inflammatory bowel disease, sepsis, and
colon cancer (Figure 1; Hecht et al., 2016). This T6SS antagonism
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between a gut resident and incoming pathogens likely contributes to
gut homeostasis.
6 | THE T6SS ARMS RACE IN THE
CONTROL OF GUT MICROBIOTA/
PATHOGEN BALANCE
If commensals use the T6SS to restrict invasion by intruders, it seems
obvious that pathogens deploy their T6SS to invade the resident
microbiota facilitating colonisation (Figure 1). Salmonella enterica Typ-
himurium is a major causative agent of human gastroenteritis. The Sal-
monella Pathogenicity Island Six encodes a T6SS cluster that
contributes to the colonisation of mice and chickens. Recent work
confirmed this role in mice and demonstrated that S. Typhimurium
exhibits T6SS antibacterial killing of Klebsiella oxytoca and Klebsiella
variicola (Sana et al., 2016). However, no killing of other Gram-
negative bacteria was observed (e.g., Enterobacter cloacae, Escherichia
coli, or commensals such as Prevotella copri, Parabacteroides distasonis,
and Bifidobacterium longum; Sana et al., 2016). This suggests the T6SS
has a defined role in colonisation, which is dependent upon
antibacterial activity, but S. Typhimurium only kills specific members
of the microbiota to invade the gut. The T6SS of pathogenic Shigella
sonnei is also required to colonise the mouse gut (Anderson,
Vonaesch, Saffarian, Marteyn, & Sansonetti, 2017). This T6SS medi-
ates out-competition of commensal E. coli or Shigella flexneri both
in vitro and in mice (Anderson et al., 2017). This confirms a role of the
T6SS in host colonisation where, via direct killing, the colonisation
resistance of the microbiota is overcome (Figure 1). This work also
shows that S. sonnei has a T6SS-mediated competitive advantage over
S. flexneri (which lacks the T6SS) and may be contributing to its
increasing global dominance over S. flexneri as the leading cause of
Shigellosis (Anderson et al., 2017). Thus, the T6SS is an antibacterial
weapon used by pathogens as a virulence factor.
Although pathogens can use the T6SS to promote colonisation,
this may not be solely via killing of the microbiota and niche takeover
but may also combine the host response. Drosophila infected with
T6SS+ V. cholerae have a reduced lifespan, enhanced intestinal dam-
age, and higher diarrheal symptoms than has T6SS− infection (Fast,
Kostiuk, Foley, & Pukatzki, 2018). However, removal of commensal
bacteria attenuated disease, as did deletion of the fly IMD
antibacterial pathway, highlighting that T6SS killing leads to secondary
events that enhance pathogenicity (Fast et al., 2018). In the mamma-
lian gut, several studies have suggested a role for the T6SS in facilitat-
ing colonisation by influencing the host response (Figures 1 and 2).
Indeed, V. cholerae T6SS-mediated antagonism and killing of mouse
commensals was shown to drive a more acute host innate immune
response with higher induction of pro-inflammatory factors (Zhao,
Caro, Robins, & Mekalanos, 2018). RNA-seq analysis corroborates this
with an upregulation of 14 host immune genes including multiple tar-
gets in the NF-κB pathway. The authors suggest that killing of the
intestinal microbiota releases microbe-associated molecular patterns
driving this response. This study also reported higher host diarrheal
symptoms in mice challenged with wild type compared with the T6SS−.
Thus, in this case, V. cholerae is using its antibacterial capacity to clear
its niche, and this killing in turn induces a host response potentially
enhancing pathogenicity and transmission (Zhao et al., 2018). In con-
trast, a study using the zebrafish (Danio rerio) model demonstrated
that V. cholerae could manipulate the host leading to ejection of
its resident microbiota (Figure 2). Delivery of the actin cross-
linking domain of vgrG-1 promoted host intestinal contractions,
dispelling the microbiota leading to enhanced V. cholerae colonisa-
tion (Logan et al., 2018). Overall, these studies show that the T6SS
can modulate the host gut environment for the pathogen's benefit
(Figure 2).
7 | FUTURE PERSPECTIVES AND
CONCLUSIONS
For many decades, the microbial composition of the mammalian gut
has been considered to play a critical role in human health, mediating
everything from immune system education, regulating endocrine func-
tion, vitamin synthesis, to protecting from pathogens (Lynch & Peder-
sen, 2016). The examples above show that the T6SS has a role in both
pathogen defence and pathogen invasion. It is attractive to consider
that specific cocktails of symbiotic bacteria or even engineered T6SS+
commensal strains may be used as the prebiotics or probiotics in the
mammalian gut, or as biocontrol agents in plants in the future. How-
ever, careful consideration is needed, as these strains may kill the
microbiota as much as the pathogen. Realistically, T6SS biocontrol is
something that is obviously best ready for plant pathogen control, and
promising work in this area has been performed (Bernal et al., 2017;
Decoin et al., 2014; Figure 2).
One additional consideration is that the control of the T6SS in
many bacteria and within the intestinal conditions is likely highly com-
plex. Experimental studies have shown that the activity of the T6SS
can be influenced by host or dietary components. Bile salts, for
instance, amplify S. Typhimurium T6SS-mediated bacterial killing (Sana
et al., 2016). Mucins or chitin have been shown to promote T6SS
expression and activity in V. cholerae (Bachmann et al., 2015; Borgeaud
et al., 2015). Intriguingly, the microbiota modify bile acids to inhibit the
T6SS of pandemic V. cholerae (Bachmann 2015). This suggests that
bacterial pathogenicity could be controlled by the addition of certain
dietary components to modulate the behaviour of the microbiota.
In summary, the T6SS is present in many Gram-negative bacteria
and found in both pathogens and nonpathogens. It can perform a
wide variety of functions, and mounting evidence shows a clear role
in modulating the microbiota (Figures 1 and 2). This can be achieved
through the direct injection of effector proteins into competing bacte-
ria, which results in their growth inhibition or death. This death may in
turn have consequences for the surrounding bacteria and the host.
T6SS effectors can also directly subvert the host for their gain, and
recent examples show that this can trigger changes to the microbiota.
As bacteria in the human gut achieve the greatest densities recorded
for any ecosystem, with an estimated 100 trillion cells, many more
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examples of T6SS-associated activities are likely to be identified.
Recent discoveries of the T6SS in killing fungus, that is, Serratia mar-
cescens T6SS effectors Tfe1 and Tfe2 killing Candida albicans, Candida
glabrata, and Saccharomyces cerevisiae (Trunk et al., 2018), or altering
the behaviour of Gram-positive bacteria, that is, Pseudomonas
chlororaphis influencing sporulation of Bacillus subtilis (Molina-
Santiago et al., 2019), are opening unprecedented scope to this
remarkable molecular weapon (Figure 2). However, the T6SS is but
one of the specialised secretion systems deployed by bacteria for
combat. For instance, diffusible colicins, the type IV secretion system,
the type V secretion system/contact-dependent inhibition systems,
and diverse type VII secretion systems have all been shown to medi-
ate bacterial killing in confined areas (Aoki et al., 2010; Cao, Casabona,
Kneuper, Chalmers, & Palmer, 2016; Gonzalez, Sabnis, Foster, &
Mavridou, 2018; Souza et al., 2015). More research will undoubtedly
discover additional effectors and systems that function as bacterial
weapons for the unabating microbial conflict, which results in innu-
merable bacterial causalities of war.
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